HomeAMGN • NASDAQ
add
Amgen Inc
Previous close
$262.23
Day range
$261.28 - $270.49
Year range
$253.30 - $346.85
Market cap
145.24B USD
Avg Volume
4.24M
P/E ratio
34.57
Dividend yield
3.52%
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 8.50B | 23.18% |
Operating expense | 3.14B | -2.61% |
Net income | 2.83B | 63.58% |
Net profit margin | 33.28 | 32.80% |
Earnings per share | 5.58 | 12.50% |
EBITDA | 3.45B | 24.59% |
Effective tax rate | 8.74% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.01B | -74.06% |
Total assets | 90.88B | 0.39% |
Total liabilities | 83.36B | 0.58% |
Total equity | 7.53B | — |
Shares outstanding | 537.53M | — |
Price to book | 18.73 | — |
Return on assets | 5.65% | — |
Return on capital | 7.52% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 2.83B | 63.58% |
Cash from operations | 3.57B | 29.38% |
Cash from investing | -210.00M | 19.85% |
Cash from financing | -3.65B | -82.09% |
Net change in cash | -290.00M | -158.82% |
Free cash flow | 2.87B | 114.60% |
About
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. As one of the world's largest independent biotechnology companies, Amgen has approximately 24,000 staff in total as of 2022.
The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics, which became the official name of the company in 1983. The company is listed on the Nasdaq Global Select Market under the ticker symbol "AMGN", as well as a component of the Nasdaq-100, the Dow Jones Industrial Average, and the S&P 100 and 500 indices. Wikipedia
Founded
Apr 8, 1980
Headquarters
Website
Employees
26,700
